Consumer CBD Sales Could Reach $2.1 Billion by 2020


Ryan Allway

October 18th, 2016

News, Top News


Consumer cannabidiol – or CBD – sales reached $85 million in 2015 and could reach $115 million this year, according to The CBD Report by The Hemp Business Journal. By 2020, the analyst projects that the market could surpass $2 billion in size as the world awakens to the benefits of the cannabinoid cousin of tetrahydrocannabinol – or THC. These revenues would be divided across a diverse set of end markets, ranging from pharmaceuticals to smoke shops.

us-hemp-based-cbd-sales-by-channel-2020

“There is real interest and awareness among customers in the natural channel who have heard about the benefits of CBD and what hemp products can do in terms of a therapeutic effect in dietary supplement form and also in products applied to the skin for muscle aches and inflammation,” said Sarah Shebanek, Wellness Buyer for Alfalfa’s Market, an independently owned natural products retailer with stores along Colorado’s Front Range. Alfalfa’s carries CBD brands including CW Hemp, Restorative Botanical, CBDRx, and BlueBird Botanicals.

The Food & Drug Administration (FDA) has raised concerns over CBD products in February 2015, warning them against making unproven health claims and noting that several products contained no CBD at all. A year later, the FDA announced that CBD products couldn’t be sold as a dietary supplement and warned companies against selling CBD-infused products. These assertions have been challenged since then by the industry and companies continue to sell CBD-based products in both online and retail establishments.

CV Sciences Inc. (CVSI) is a leader in the CBD category with products in over 500 brick and mortar retailers. Since its products are developed with hemp rather than marijuana, the company believes that its products don’t fall under these onerous restrictions.

“CV Sciences is pioneering CBD products in the health and wellness space vs. the cannabis space,” said Sarah Syed, Director of Marketing for CV Sciences. “We understand the ‘green rush’ is here, but we are hoping to appeal to everyday folks, soccer moms, athletes, professionals, etc. We see CBD as more a dietary supplement that can help keep people healthy.”

The bioabsorption of CBDs is also becoming an important consideration with companies like Lexaria Energy (LXRP) developing new delivery mechanisms.

According to Chris Bunka, the CEO of Lexaria Energy, “When someone smokes a joint the industry average is 32% bio-active in the bloodstream, and can be as high as 60%. Sublinguals are generally 12%-14%, hemp oils range from 6%-10% and typical bio-actives in functional foods are 4%-6%. We performed in-vitro testing on absorption rates with our bonding technology in CBD energy bars. Absorption was 500% higher for intestinal cells.”

Investors may want to keep a close eye on the CBD industry as it continues to mature, particularly as the regulatory picture clears up over the coming years. With several companies active in the space, there are many opportunities to get involved in the industry.

Purchase The CBD Report through CFN Media for a 20% discount. The CBD Report is the definitive report for market sizes and high-level analysis of business trends in the CBD (cannabidiol) industry. The first report of its kind, the CBD Report is a 40 page document filled with primary research, market intelligence, investment analysis, data charts, and insights from more than 55 interviews from business leaders.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading